Precigen Investor

Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.

Invests into

Technology: CAR-T therapy, Cell_Therapies
Industry: Public
Headquarters: Germantown, Maryland, United States
Founded Date: 1998-01-01
Employees Number: 251-500
Funding Status: IPO
Number Of Exits: 1
Investors Number: 3
Total Funding: 600803901
Estimated Revenue: $10M to $50M
Last Funding Date: 2023-01-24
Last Funding Type: Post-IPO Equity

Visit Website
swright@intrexon.com
https://twitter.com/precigen
Register and Claim Ownership